Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0DA1U
|
|||
| Drug Name |
C7R-GD2.CART cells
|
|||
| Drug Type |
CAR T Cell Therapy
|
|||
| Indication | Neuroblastoma [ICD-11: 2D11.2] | Phase 1 | [1] | |
| Company |
Baylor College of Medicine
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Ganglioside GD2 (GD2) | Target Info | CAR-T-Cell-Therapy | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03635632) C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma (GAIL-N) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.